首页> 外文期刊>International Journal of Pharmaceutics >Determining the simultaneous presence of drug nanocrystals in drug-loaded polymeric nanocapsule aqueous suspensions: a relation between light scattering and drug content.
【24h】

Determining the simultaneous presence of drug nanocrystals in drug-loaded polymeric nanocapsule aqueous suspensions: a relation between light scattering and drug content.

机译:确定在载有药物的聚合物纳米胶囊水性悬浮液中同时存在药物纳米晶体:光散射与药物含量之间的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

The encapsulation of lipophilic drugs in polymeric nanoparticles can form simultaneously both polymeric nanoparticles and drug nanocrystals. The objective was to detect the presence of nanocrystals in the nanoparticle suspensions using a simple methodology, and to determine if the nanocrystals are formed during preparation or by drug leakage from the particles during storage. Indomethacin was chosen as drug model. Unloaded and drug-loaded (1mg/mL) nanocapsules showed diameters close to 280nm and polydispersity lower than 0.20, remaining constant after 120 days. Comparing indomethacin loaded (3mg/mL) and unloaded formulations, variations in the scattered light depolarization degree indicated the simultaneous presence of nanocrystals and nanocapsules in the suspensions. A relation between the scattered light intensities and the drug precipitation was established. As a function of time, when the decrease in the Rayleigh ratios occurred, the drug contents decreased due to precipitation. On the other hand, when the Rayleigh ratios slightly increase, the drug contents are constant. The nanocrystals formed in the oversaturated formulations, agglomerate and precipitate during storage. When the drug is adsorbed on the nanocapsules, but the system is not oversaturated, no nanocrystal was formed and the formulation is physico-chemically stable at least for 150 days of storage.
机译:亲脂性药物在聚合物纳米颗粒中的包封可以同时形成聚合物纳米颗粒和药物纳米晶体。目的是使用一种简单的方法来检测纳米颗粒悬浮液中纳米晶体的存在,并确定纳米晶体是在制备过程中形成还是在储存过程中从颗粒中漏出而形成。选择消炎痛作为药物模型。空载和载药(1mg / mL)纳米胶囊的直径接近280nm,多分散度低于0.20,在120天后保持不变。比较负载消炎痛(3mg / mL)和负载消炎痛的制剂,散射光去极化度的变化表明悬浮液中同时存在纳米晶体和纳米胶囊。建立了散射光强度与药物沉淀之间的关系。作为时间的函数,当瑞利比降低时,药物含量由于沉淀而降低。另一方面,当瑞利比稍微增加时,药物含量是恒定的。在储存过程中,过饱和配方中形成的纳米晶体会聚结并沉淀。当药物吸附在纳米胶囊上,但系统未发生过饱和时,则不会形成纳米晶体,并且该制剂至少在150天的储存中是物理化学稳定的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号